DEXTRAN 40 FOR INJECTION
Diabetes Type 2
University of Colorado, Denverother_biologicalActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Diabetes Type 2 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide University of Maryland, Baltimore | Phase 4 | BBB |
URSODEOXYCHOLIC ACID Asmaa Abdelfattah Elsayed | Phase 4 | BB |
Pentoxifylline Asmaa Abdelfattah Elsayed | Phase 4 | BB |
Same molecule, other indications
DEXTRAN 40 FOR INJECTION is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →